So Russian Regulatory approval for selling reopren in place
Factory operating and storing product.
Orders are in and AWAITING delivery.
All is ok only ANZ put a hold but nearly fixed.
What more can one say.
Estimated cost of a course a little low but reading between the lines that will be upted when ready to run the shareprice. Bring on the EGM I say.Imagine if they recosted the course to $3000.00 why wouldnt it be the similar price to N.Z.
Add to My Watchlist
What is My Watchlist?
